Trichomoniasis occupies first place among diseases of the genitourinary
tract. In addition, trichomoniasis is top among sexually transmitted diseases.
According to the World Health Organization, 35% of the world’s population suffers from trichomoniasis. Men and women suffer from trichomoniasis with equal frequency, although the disease among in men usually goes unnoticed.
Urethritis caused by trichomonas may be accompanied by a slight mucous discharge which does not cause any concern.
As men practically remain healthy and unaware of the disease,it is not treated and he serves as a constant source of infection.
Symptoms among men: the disease is usually asymptomatic.
Sometimes men with trichomoniasis have the following symptoms:
urethral discharge, pain and burning during urination,and lesions of the prostate, which are symptoms of prostatitis.
In men, prostatitis is the most common complication of trichomoniasis.
Untreated trichomoniasis can lead to the spread of inflammation in the epididymis, which is often causes infertility and can become chronic and difficult to treat.
Symptoms among women: vaginal discharge (usually yellow,sometimes with an unpleasant smell); itching and redness of the vulva; pain during urination, pain during sexual intercourse.
In the course of chronic trichomoniasis, there may be no symptoms, but they appear when there is a weakening of the immune system.
Diagnosis. Most often, clinical diagnosis can be confirmed by
microscopy of moist smears. To confirm diagnosis, PCR of a normal
smear is repeated.
Treatment programs are recommended based on clinical findings. In an acute process, the program is used 2-4 times daily until symptoms disappear, but for not less than 10 days.
In chronic carrier states: 1-2 times per day for 10-14 days. After completing a treatment program, a drainage program should be added to prevent intoxication.
Sexual partners must be treated to avoid reinfection.
The criteria for recovery is:
• the disappearance of clinical symptoms,
• the negative PCR results.
Microscopic examination shall be carried out not earlier than 1-2 weeks after treatment due to the possibility of obtaining false negative results. DNA diagnostics (PCR) carried out less than 3-4 weeks after treatment may provide false positive results due to the possible retention of devitalized microorganisms or their remnants.
Detection of trichomoniasis by a control after this deadline requires repetition of the course of therapy for 2 weeks. It is appropriate to conduct laboratory examination before and after treatment in the same laboratory, using the same diagnostic tests.